TCG CROSSOVER MANAGEMENT, LLC Entrada Therapeutics, Inc. Transaction History

TCG CROSSOVER MANAGEMENT, LLC portfolio value:

$10.12M
portfolio value

TCG CROSSOVER MANAGEMENT, LLC quarter portfolio value change:

+29.39%
quarter

Entrada Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -3.24% -21.50K shares 2.03M $15.76 642.18K
Q2 2022 share 0.00% 0 shares 1.95M $12.18 663.69K
Q1 2022 share 0.00% 0 shares -5.22M $9.39 663.69K
Q4 2021 share Increase 0.00% 663.69K shares 11.36M $18.37 663.69K